Skip to main content
. 2020 Mar;8(5):234. doi: 10.21037/atm.2019.12.158

Figure 1.

Figure 1

CONSORT diagram. The efficacy and safety analysis populations included patients who received at least one dose of study therapy, received cisplatin-based chemotherapy, and had at least one post-treatment efficacy assessment. FAS, full analysis set; SS, safety set; PPS, per protocol set.